Relmada Therapeutics Announces Publication of REL-1017 Phase 2 Study Results in The American Journal of Psychiatry - Yahoo Finance

Submitted by Anonymous (not verified) on Wed, 12/22/2021 - 14:02

Relmada Therapeutics Announces Publication of REL-1017 Phase 2 Study Results in The American Journal of Psychiatry  Yahoo Finance